Hastings Ian M, Hardy Diggory, Kay Katherine, Sharma Raman
Liverpool School of Tropical Medicine Liverpool UK.
Swiss Tropical and Public Health Institute Basel Switzerland.
Evol Appl. 2020 Aug 11;13(10):2723-2739. doi: 10.1111/eva.13077. eCollection 2020 Dec.
Control strategies for human infections are often investigated using individual-based models (IBMs) to quantify their impact in terms of mortality, morbidity and impact on transmission. Genetic selection can be incorporated into the IBMs to track the spread of mutations whose origin and spread are driven by the intervention and which subsequently undermine the control strategy; typical examples are mutations which encode drug resistance or diagnosis- or vaccine-escape phenotypes.
We simulated the spread of malaria drug resistance using the IBM OpenMalaria to investigate how the finite sizes of IBMs require strategies to optimally incorporate genetic selection. We make four recommendations. Firstly, calculate and report the selection coefficients, , of the advantageous allele as the key genetic parameter. Secondly, use these values of "" to calculate the wait time until a mutation successfully establishes itself in the pathogen population. Thirdly, identify the inherent limits of the IBM to robustly estimate small selection coefficients. Fourthly, optimize computational efficacy: when "" is small, fewer replicates of larger IBMs may be more efficient than a larger number of replicates of smaller size.
The OpenMalaria IBM of malaria was an exemplar and the same principles apply to IBMs of other diseases.
人类感染控制策略通常使用基于个体的模型(IBM)进行研究,以量化其在死亡率、发病率以及对传播的影响方面的作用。遗传选择可纳入IBM中,以追踪突变的传播,这些突变的起源和传播由干预措施驱动,随后会破坏控制策略;典型例子是编码耐药性或诊断逃避或疫苗逃避表型的突变。
我们使用IBM OpenMalaria模拟疟疾耐药性的传播,以研究IBM的有限规模如何要求采用策略来最佳地纳入遗传选择。我们提出四条建议。首先,计算并报告优势等位基因的选择系数,作为关键遗传参数。其次,使用这些“”值计算突变在病原体群体中成功确立自身所需的等待时间。第三,确定IBM在稳健估计小选择系数方面的固有局限性。第四,优化计算效率:当“”较小时,较大规模IBM的较少重复次数可能比较小规模的大量重复次数更有效率。
疟疾的OpenMalaria IBM是一个范例,同样的原则也适用于其他疾病的IBM。